Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134755 · ClinicalTrials.gov registry record
Stress and Treatment Response in Puerto Rican Children With Asthma
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 249
- Enrollment target
NCT03134755: Completed study, sponsored by University of Pittsburgh.
NCT03134755 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 249 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03134755 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 249 participants
- Enrollment target
Study Summary
This study aims to first determine whether high child stress leads to reduced response to common treatmenIs for asthma (inhaled corticosteroids and short-acting bronchodilators), and then to identify DNA methylation differences leading to stress-induced treatment resistance among children with asthma.
Primary Outcome
BDR will be measured as the change in forced expiratory volume in 1 second (FEV1) after administration of a short-acting bronchodilator (albuterol)
Interventions
- DRUG Inhaled corticosteroid (mometasone)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2018-05-15 |
| Est. Completion | 2022-05-18 |
What the finished NCT03134755 record still lists
NCT03134755 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Inhaled corticosteroid (mometasone) is the first listed.
NCT03134755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03134755 about?
NCT03134755 is a clinical study titled "Stress and Treatment Response in Puerto Rican Children With Asthma". This study aims to first determine whether high child stress leads to reduced response to common treatmenIs for asthma (inhaled corticosteroids and short-acting bronchodilators), and then to identify DNA methylation differences leading to stress-induced treatment resistance among children with asthm...
What is the current status of trial NCT03134755?
This trial is currently completed. The enrollment target is 249 participants. The study started on 2018-05-15. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT03134755?
The interventions under investigation include: Inhaled corticosteroid (mometasone) (DRUG).
Who is sponsoring clinical trial NCT03134755?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI